--- title: "周三交易中，作为美国存托凭证交易的欧洲股票上涨" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/273260837.md" description: "在美国交易的欧洲股票的美国存托凭证上涨，S&P Europe Select ADR Index 上涨了 0.49%，达到 1,744.86。显著上涨的公司包括 BioNTech（+4.8%）和 Equinor（+2.6%），而下跌的公司包括 Novo Nordisk（-3.3%）和 Ascendis Pharma（-2.2%）。来自英国和爱尔兰的 Silence Therapeutics 以 7.9% 的涨幅领涨，而 Mereo BioPharma Group 则下跌了 7.3%" datetime: "2026-01-21T16:16:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/273260837.md) - [en](https://longbridge.com/en/news/273260837.md) - [zh-HK](https://longbridge.com/zh-HK/news/273260837.md) --- # 周三交易中，作为美国存托凭证交易的欧洲股票上涨 11:16 AM EST, 01/21/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.49% to 1,744.86 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and petroleum refiner Equinor ( EQNR ) , which advanced 4.8% and 2.6% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and semiconductor company Sequans Communications ( SQNS ) , which rose 2.1% and 1.7% respectively. The decliners from continental Europe were led by pharmaceutical companies Novo Nordisk ( NVO ) and Ascendis Pharma ( ASND ) , which fell 3.3% and 2.2% respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biotech firm Evaxion ( EVAX ) , which lost 1.9% and 1.7% respectively. From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and educational publisher Pearson (PSO), which increased 7.9% and 2.8% respectively. They were followed by software firm Endava ( DAVA ) and biopharmaceutical company NuCana ( NCNA ) , which were up 2.7% and 2.2% respectively. The decliners from the UK and Ireland were led by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Amarin ( AMRN ) , which dropped 7.3% and 2.7% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company AstraZeneca ( AZN ) , which were down 1.8% and 0.6% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相关股票 - [IHI.US](https://longbridge.com/zh-CN/quote/IHI.US.md) - [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md) - [SPEU.US](https://longbridge.com/zh-CN/quote/SPEU.US.md) - [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md) - [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md) - [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [SSEHF.US](https://longbridge.com/zh-CN/quote/SSEHF.US.md) - [IXJ.US](https://longbridge.com/zh-CN/quote/IXJ.US.md) - [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md) - [XLV.US](https://longbridge.com/zh-CN/quote/XLV.US.md) - [VHT.US](https://longbridge.com/zh-CN/quote/VHT.US.md) - [IHE.US](https://longbridge.com/zh-CN/quote/IHE.US.md) - [BNTX.US](https://longbridge.com/zh-CN/quote/BNTX.US.md) - [NVO.US](https://longbridge.com/zh-CN/quote/NVO.US.md) - [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md) - [ASND.US](https://longbridge.com/zh-CN/quote/ASND.US.md) - [IBBQ.US](https://longbridge.com/zh-CN/quote/IBBQ.US.md) - [ARKG.US](https://longbridge.com/zh-CN/quote/ARKG.US.md) - [EQNR.US](https://longbridge.com/zh-CN/quote/EQNR.US.md) - [SLN.US](https://longbridge.com/zh-CN/quote/SLN.US.md) - [MREO.US](https://longbridge.com/zh-CN/quote/MREO.US.md) - [STOHF.US](https://longbridge.com/zh-CN/quote/STOHF.US.md) - [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md) - [XHE.US](https://longbridge.com/zh-CN/quote/XHE.US.md) ## 相关资讯与研究 - [国信证券：2026 年内关注口服减重药物商业化进展 MNC 在 CVRM 赛道布局更新](https://longbridge.com/zh-CN/news/287148565.md) - [Silence Therapeutics｜8-K：2026 财年 Q1 营收 42.2 万美元](https://longbridge.com/zh-CN/news/285549766.md) - [Aethlon Medical 密切关注刚果埃博拉疫情，重申大流行应对准备](https://longbridge.com/zh-CN/news/287246948.md) - [百时美施贵宝向 3 万名员工全面开放 Anthropic 公司 Claude](https://longbridge.com/zh-CN/news/287085684.md) - [强生重症肌无力治疗新药获国家药监局批准上市](https://longbridge.com/zh-CN/news/287196062.md)